<DOC>
	<DOCNO>NCT01253122</DOCNO>
	<brief_summary>A randomised four way crossover design subject receive two dose level TRx-0037 two dos TRx-0014 approximately four week period randomise order .</brief_summary>
	<brief_title>Comparative Bioavailability Healthy Elderly Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Male female 55 No clinically important abnormal physical finding No clinically significant lab result Normal ECG , Normal BP HR , BMI 19 32 Weight 50 100 kg , Able communicate Provide write informed consent Non smoker Males use contraception Females surgically sterile post menopausal Administration IMP study drug within 12 week entry Use prescribe med , St John 's wort , counter med describe protocol Surgical medical condition might interfere IMP History drug alcohol abuse Clinically significant allergy require treatment Loss great 400ml blood within 12 week . Serious adverse reaction hypersensitivity drug Prescence Hep B , Hep c HIV1 HIV2 screen Presence G6PD screen History methaemoglobinaemia Partner pregnant lactate Positive Pregnancy test</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
</DOC>